Vector biocontrol,
in local hands.
Mosquito-borne diseases put billions of people at risk. We help countries adopt proven biocontrol methods and build the capability, systems and skills to run them in their own cities.
Biocontrol methods such as Wolbachia mosquito releases have demonstrated success, but success in one country does not put a working programme in another. That takes an insectary that runs every day, a laboratory that monitors mosquito quality and Wolbachia establishment, field teams who know the landscape, and data that shows whether the programme is working. Astare builds those capabilities with the institutions that will run them, and stays until they can operate independently.
Astare is an Australian science company specialising in technology transfer for the biocontrol of mosquito-borne diseases, including dengue, malaria and yellow fever. We work with governments and research institutions to put scientifically validated methods into practice at city scale and build the local capability to sustain them.
Our work spans three areas: technology transfer, from facility set-up to field deployment; surveillance and evidence, from mosquito monitoring to trial design and analysis; and local capability, through practical training, standard operating procedures and support for independent operations.
Samia Elfekih, MBA, PhD
Principal Research Scientist at Astare, with fifteen years of experience in vector-borne disease research and programme leadership, working with government, university and industry partners across the Middle East, Europe and Australia. Technology transfer lead for KACST's Jeddah Integrated Dengue Biocontrol Programme.
“We take proven science where it has never been tried, and show what works.”
Built on published, peer‑reviewed science.
Astare's methods rest on published research. Selected publications from the Jeddah programme are listed below.
